Mauriello Alfredo, Correra Adriana, Quagliariello Vincenzo, Iovine Martina, Di Micco Pierpaolo, Imbalzano Egidio, Giallauria Francesco, Giordano Antonio, Russo Vincenzo, D'Andrea Antonello, Maurea Nicola
Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy.
Intensive Cardiac Care Unit, "San Giuseppe Moscati" Hospital, ASL Caserta, 81031 Aversa, Italy.
J Clin Med. 2025 Aug 7;14(15):5600. doi: 10.3390/jcm14155600.
Atrial fibrillation is the most frequent arrhythmia in elderly subjects. Cancer currently represents one of the most important causes of mortality and morbidity in the world. Often, the two pathologies coexist. Several pathophysiological mechanisms can lead to an increased risk of atrial fibrillation and cancer. Additionally, the same therapies used for cancer can increase the risk of developing atrial fibrillation. Our review aims to describe the pathophysiological mechanisms that promote the development of atrial fibrillation in cancer patients and explain the therapeutic opportunities and challenges of treating atrial fibrillation in patients with cancer.
心房颤动是老年患者中最常见的心律失常。癌症是目前全球最重要的死亡和发病原因之一。这两种疾病常常并存。多种病理生理机制可导致心房颤动和癌症的风险增加。此外，用于治疗癌症的相同疗法也会增加发生心房颤动的风险。我们的综述旨在描述促使癌症患者发生心房颤动的病理生理机制，并解释治疗癌症患者心房颤动的治疗机会和挑战。
